Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Lestage

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Neuropharmacology|December 17, 2009
Modulatory effects of S 38232, a non alpha-7 containing nicotine acetylcholine receptor agonist on network activity in the mouse hippocampusLaura Lagostena, Laurence Danober, Sylvie Challal, et al.
CNS Drug Reviews|June 19, 2002
S 17092: a prolyl endopeptidase inhibitor as a potential therapeutic drug for memory impairment. Preclinical and clinical studiesPhilippe Morain, Pierre Lestage, Guillaume De Nanteuil, et al.
CNS Neuroscience & Therapeutics|November 6, 2010
DRUG FOCUS: S 18986: A positive allosteric modulator of AMPA-type glutamate receptors pharmacological profile of a novel cognitive enhancerKaty Bernard, Laurence Danober, Jean-Yves Thomas, et al.
European Journal of Medicinal Chemistry|February 21, 2003
Synthesis and pharmacological evaluation of new 1,2-dithiolane based antioxidantsClaude Guillonneau, Yves Charton, Yves-Michel Ginot, et al.
Neuropharmacology|June 5, 2007
Partial agonist and neuromodulatory activity of S 24795 for alpha7 nAChR responses of hippocampal interneuronsGretchen Lopez-Hernandez, Andon N Placzek, Jeffrey S Thinschmidt, et al.
European Journal of Pharmacology|March 3, 2007
S18986: a positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal culturesBrian Paul Lockhart, Marianne Rodriguez, Sophie Mourlevat, et al.
Journal of Chemical Information and Modeling|November 25, 2014
Thermodynamic characterization of new positive allosteric modulators binding to the glutamate receptor A2 ligand-binding domain: combining experimental and computational methods unravels differences in driving forcesAnn-Beth Nørholm, Pierre Francotte, Eric Goffin, et al.
Bioorganic & Medicinal Chemistry|November 5, 2008
Synthesis and pharmacological evaluation of a second generation of pyridothiadiazine 1,1-dioxides acting as AMPA potentiatorsPierre Francotte, Pascal de Tullio, Tchao Podona, et al.
Plos One|October 11, 2012
In vivo cross-sectional characterization of cerebral alterations induced by intracerebroventricular administration of streptozotocinAudrey Kraska, Mathieu D Santin, Olène Dorieux, et al.
ACS Chemical Neuroscience|January 16, 2016
Synthesis and Pharmacology of Mono-, Di-, and Trialkyl-Substituted 7-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides Combined with X-ray Structure Analysis to Understand the Unexpected Structure-Activity Relationship at AMPA ReceptorsAnja Probst Larsen, Pierre Francotte, Karla Frydenvang, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Neuropharmacology|December 17, 2009
Modulatory effects of S 38232, a non alpha-7 containing nicotine acetylcholine receptor agonist on network activity in the mouse hippocampusLaura Lagostena, Laurence Danober, Sylvie Challal, et al.
CNS Drug Reviews|June 19, 2002
S 17092: a prolyl endopeptidase inhibitor as a potential therapeutic drug for memory impairment. Preclinical and clinical studiesPhilippe Morain, Pierre Lestage, Guillaume De Nanteuil, et al.
CNS Neuroscience & Therapeutics|November 6, 2010
DRUG FOCUS: S 18986: A positive allosteric modulator of AMPA-type glutamate receptors pharmacological profile of a novel cognitive enhancerKaty Bernard, Laurence Danober, Jean-Yves Thomas, et al.
European Journal of Medicinal Chemistry|February 21, 2003
Synthesis and pharmacological evaluation of new 1,2-dithiolane based antioxidantsClaude Guillonneau, Yves Charton, Yves-Michel Ginot, et al.
Neuropharmacology|June 5, 2007
Partial agonist and neuromodulatory activity of S 24795 for alpha7 nAChR responses of hippocampal interneuronsGretchen Lopez-Hernandez, Andon N Placzek, Jeffrey S Thinschmidt, et al.
European Journal of Pharmacology|March 3, 2007
S18986: a positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal culturesBrian Paul Lockhart, Marianne Rodriguez, Sophie Mourlevat, et al.
Journal of Chemical Information and Modeling|November 25, 2014
Thermodynamic characterization of new positive allosteric modulators binding to the glutamate receptor A2 ligand-binding domain: combining experimental and computational methods unravels differences in driving forcesAnn-Beth Nørholm, Pierre Francotte, Eric Goffin, et al.
Bioorganic & Medicinal Chemistry|November 5, 2008
Synthesis and pharmacological evaluation of a second generation of pyridothiadiazine 1,1-dioxides acting as AMPA potentiatorsPierre Francotte, Pascal de Tullio, Tchao Podona, et al.
Plos One|October 11, 2012
In vivo cross-sectional characterization of cerebral alterations induced by intracerebroventricular administration of streptozotocinAudrey Kraska, Mathieu D Santin, Olène Dorieux, et al.
ACS Chemical Neuroscience|January 16, 2016
Synthesis and Pharmacology of Mono-, Di-, and Trialkyl-Substituted 7-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides Combined with X-ray Structure Analysis to Understand the Unexpected Structure-Activity Relationship at AMPA ReceptorsAnja Probst Larsen, Pierre Francotte, Karla Frydenvang, et al.
Pageof 4